Mallinckrodt

Rejected: After paying $80M to acquire it, Mallinckrodt’s jaundice drug snubbed by FDA’s advisory committee
Endpoints
Thu, 05/3/18 - 11:09 pm
Mallinckrodt
FDA
advisory panels
infantile jaundice
InfaCare
stannsoporfin
Mallinckrodt used 'dirty data' to snow payers on Acthar, whistleblower suit says
Fierce Pharma
Fri, 04/13/18 - 01:14 pm
Mallinckrodt
whistleblower lawsuits
H.P. Acthar Gel
fraud
Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis
Fierce Pharma
Thu, 03/1/18 - 11:51 pm
Mallinckrodt
oxymorphone
opioid crisis
Mallinckrodt builds pipeline through $1.2B Sucampo deal
Biopharma Dive
Thu, 12/28/17 - 09:20 am
Mallinckrodt
Sucampo
M&A
Mallinckrodt continues pipeline revamp with Ocera buy
BioPharma Dive
Sat, 11/4/17 - 08:50 am
Mallinckrodt
Ocera Therapeutics
M&A
Mallinckrodt bags another microcap biotech, picking up Ocera’s failed drug in $117M buyout
Endpoints
Thu, 11/2/17 - 09:17 am
Mallinckrodt
Ocera Therapeutics
M&A
Mallinckrodt stifled Acthar competition, payer lawsuit claims, clearing path for 85,000% rise in prices
Fierce Pharma
Tue, 10/31/17 - 09:13 pm
Mallinckrodt
Acthar
payers
Questcor
drug pricing
Mallinckrodt tumbles after judge invalidates Inomax patents
BioPharma Dive
Wed, 09/6/17 - 08:34 pm
Mallinckrodt
Inomax
patents
Praxair
Mallinckrodt beats Q2 earnings, misses on revenue
Drug Delivery Business News
Tue, 08/8/17 - 11:21 pm
Mallinckrodt
earnings
Mallinckrodt bags late-stage infantile jaundice drug in $425M InfaCare buyout deal
Endpoints
Mon, 08/7/17 - 11:25 am
Mallinckrodt
infantile jaundice
InfaCare
M&A
Stanate
In a critical year for drugmakers, campaign donations, PAC activity are on the rise
Stat
Mon, 07/24/17 - 11:02 am
PACs
campaign donations
Mallinckrodt
lobbying
Mallinckrodt Pharmaceuticals is facing scrutiny over the price of its blockbuster drug Acthar
Business Insider
Tue, 06/20/17 - 09:27 am
drug pricing
Mallinckrodt
Acthar
PBMs
Express Scripts
3 Biotech Stocks That Could Become M&A Targets
Motley Fool
Sat, 06/17/17 - 03:05 pm
biotech
M&A
Mallinckrodt
Tesaro
Incyte
Is Mallinckrodt in Talks to Be Sold?
Motley Fool
Tue, 06/13/17 - 10:14 pm
Mallinckrodt
M&A
Instant Analysis: Mallinckrodt Considering Sale of Generics Unit
Motley Fool
Thu, 06/1/17 - 08:48 am
Mallinckrodt
generics
M&A
Mallinckrodt exits PhRMA before new rules take hold
BioPharma Dive
Thu, 04/6/17 - 11:56 pm
Mallinckrodt
PhRMA
R&D
Mallinckrodt to settle oxycodone diversion case for $35M with Justice Department
Fierce Pharma
Tue, 04/4/17 - 12:24 am
Mallinckrodt
DOJ
oxycodone
DEA
Covidien spinout Mallinckrodt closes $690m sale of nuclear imaging biz
Mass Device
Mon, 01/30/17 - 11:53 am
Covidien
Mallinckrodt
M&A
nuclear imaging
devices
Martin Shkreli: Mallinckrodt Will Be Punished
Benzinga
Thu, 01/19/17 - 08:35 am
Martin Shkreli
Mallinckrodt
Questcor
Daraprim
The Most Expensive Drugs of 2016
Motley Fool
Mon, 12/19/16 - 11:32 am
drug pricing
Gilead Sciences
Harvoni
Sovaldi
H.P. Acthar
Mallinckrodt
Shire
Cinryze
Daklinza
Bristol-Myers Squibb

Pages